XRAYNasdaqDental Equipment & SuppliesUS GAAP · USD

DENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc. makes professional dental equipment, digital workflow technologies, consumable dental products, and selected continence-care consumables. The company sells through a global network of distributors and direct channels to dental professionals, laboratories, and medical supply distributors, with operations centered in the United States and a broad international footprint.

Kysy yhtiöstä
Liikevaihto3 680milj. USD
−3,0 %v/v
Liikevoitto (EBIT)−422milj. USD
+52,0 %v/v
EBIT-marginaali−11,5%
+11,7 %-yks.v/v
Nettotulos−598milj. USD
+34,3 %v/v
Vapaa kassavirta235milj. USD
−49,0 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−2 00002 0004 0006 000milj. USD2020: 3 339 milj. USD2020: EBIT −3,0 milj. USD20202021: 4 251 milj. USD2021: EBIT 622 milj. USD20212022: 3 922 milj. USD2022: EBIT −937 milj. USD20222023: 3 965 milj. USD2023: EBIT −85 milj. USD20232024: 3 793 milj. USD2024: EBIT −879 milj. USD20242025: 3 680 milj. USD2025: EBIT −422 milj. USD20253 680−422
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: DENTSPLY SIRONA Inc

Liiketoiminta

Osuus liikevaihdosta
Connected Technology Solutions30 %

Dental technology and equipment, including equipment & instruments and CAD/CAM systems tied to digital workflows.

Essential Dental Solutions35 %

Value-added endodontic, restorative, preventive, and small equipment products used in routine dental care.

Orthodontic and Implant Solutions20 %

Dental implants, clear aligners, and related prosthetic and orthodontic products for specialized care.

Wellspect Healthcare15 %

Healthcare consumable products for urological and enterological applications.

Asiakkaat

The company sells primarily to dental distributors, dental professionals, dental laboratories, and dental support organizations, with some products sold directly in certain markets. Its healthcare consumables are sold mainly through medical supply distributors, with some direct sales to patients and providers. Demand is driven by clinical need, installed-base replacement cycles, and adoption of digital dentistry workflows.

Dental distributors

Purchase equipment, consumables, and technology for resale; important because a large share of sales flows through third parties.

Dental professionals and specialists

Buy endodontic, restorative, preventive, implant, and digital workflow products to treat patients and improve efficiency.

Dental laboratories

Buy CAD/CAM and digital workflow tools to produce restorations and appliances.

Dental Support Organizations

Buy standardized equipment and consumables across multi-site practices, influencing pricing and product mix.

Medical supply distributors and healthcare providers

Buy Wellspect continence-care consumables for distribution to patients and care settings.

Strategia

The company is focused on connecting its dental portfolio through digital workflows, cloud-enabled software, and integrated equipment and consumables. It is also working to diversify distribution, strengthen partner relationships, and support growth in the United States while managing pricing pressure and competitive intensity.

Build connected digital workflowsKeskipitkä aikaväli

Integrated hardware, software, and consumables can improve customer retention and differentiate the portfolio.

Diversify and stabilize distributionLyhyt aikaväli

Revenue concentration with a few distributors creates channel risk and bargaining pressure.

Defend brand and product quality

Quality perception and clinical trust are central to pricing power and repeat purchases.

Maantiede

Q1/2026

Dentsply Sirona is headquartered in Charlotte, North Carolina and sells into approximately 140 countries. The United States is the core operating base, while Europe is especially important, with long-established presence in Germany, Sweden, France, the UK, Italy, and Switzerland; the company also has meaningful exposure to Asia-Pacific, Latin America, the Middle East, and Canada.

EMEA49 %
Americas38 %
Asia Pacific13 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

The business is exposed to distributor concentration, pricing pressure, and channel disruption because a large share of sales runs through third-party partners. It also faces cybersecurity, regulatory, and product-quality risks as more of the portfolio becomes cloud-connected and clinically embedded. Goodwill and intangible asset impairment risk is meaningful given recent write-downs and weaker volumes in some product lines.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Goodwill and intangible asset impairment1Distributor concentration2Product quality and regulatory compliance3Cybersecurity and IT disruption4Competitive pricing pressure5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Goodwill and intangible asset impairmentVaikutus: KorkeaTodennäköisyys: Korkea

    Lower projected volumes, tariffs, and competition can reduce fair values below carrying values.

    Kohdistuu: Implant & Prosthetic Solutions and certain trade names

  2. Distributor concentrationVaikutus: KorkeaTodennäköisyys: Kohtalainen

    A substantial portion of revenue comes through a limited number of distributors, creating dependence and pricing leverage issues.

    Kohdistuu: Henry Schein and Patterson are key channel partners

  3. Product quality and regulatory complianceVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Dental and medical products are safety-sensitive and subject to extensive regulation.

    KohdistuuGlobal manufacturingSalesDistribution
  4. Cybersecurity and IT disruptionVaikutus: KorkeaTodennäköisyys: Matala

    Cloud-based workflows and connected devices increase attack surface and operational dependence on systems.

    KohdistuuDS CoreERP systemsCloud-native scanners
  5. Competitive pricing pressureVaikutus: KeskitasoTodennäköisyys: Korkea

    Consolidation among dental practices and distributor competition can compress margins and reduce share.

    KohdistuuDental consumablesEquipmentImplantsAligners
Kysy Clarifolta: DENTSPLY SIRONA Inc

Kirjanpito

Harkinnanvaraiset erät
Goodwill impairment

The company recorded impairment charges when fair values fell below carrying values, affecting operating results and balance sheet value.

Vaikutus: Material non-cash charges, especially in Implant & Prosthetic Solutions

Indefinite-lived intangible asset impairment

Trade names and trademarks are tested for impairment and can be written down when expected cash flows weaken.

Vaikutus: Non-cash charges and reduced asset base

Revenue timing through distributors

A large share of sales goes through third-party distributors, so channel inventory and ordering patterns affect quarterly revenue.

Vaikutus: Quarter-to-quarter volatility and comparability

Foreign currency translation

Global sales create translation effects that can distort underlying demand trends.

Vaikutus: Reported growth versus constant-currency growth

Income tax valuation allowances

Discrete tax items and valuation allowances can materially change the effective tax rate.

Vaikutus: Net income volatility

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Envista Holdings Corp

NVST · Dental Equipment & Supplies

Syra Health Corp

SYRA · Services-Employment Agencies

Henry Schein, Inc

HSIC · Wholesale-Medical, Dental & Hospital Equipment & Supplies

Serina Therapeutics, Inc.

SER · Pharmaceutical Preparations

Crona Corp.

CCCP · Services-Business Services, NEC

Danaher Corporation

DHR · Industrial Instruments For Measurement, Display, and Control

Päivitetty: 24.9.2026

DENTSPLY SIRONA Inc (XRAY) liikevaihto, tulos ja tunnusluvut 2025 – Clarifo